Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Myeloid 4Lymphoid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 63fludarabine phosphate 52Busulfan 48Cyclosporine 37Antilymphocyte Serum 36Peripheral Blood Stem Cell Transplantation 35Cytarabine 29Filgrastim 28Mycophenolic Acid 27Whole-Body Irradiation 26Radiotherapy 26Melphalan 26Cord Blood Stem Cell Transplantation 24Tacrolimus 23Methotrexate 23Methylprednisolone 21fludarabine 19Etoposide 16Thiotepa 11Granulocyte Colony-Stimulating Factor 11Azacitidine 10Alemtuzumab 9Daunorubicin 8sargramostim 7Idarubicin 7Decitabine 7Biopsy 7Topotecan 6Stem Cell Transplantation 6Mitoxantrone 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myelodysplastic Syndromes × posaconazole × Classical hematology × Clear all
NCT02875743 2020-04-02

King's Invasive Aspergillosis Study II

King's College Hospital NHS Trust

Phase 4 Completed
120 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Aplastic, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡